SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

Treasure Global is trending due to a recent revenue target update and chatter around its low float, sparking comparisons to other high-flying stocks like $SMX. Community members are actively discussing the potential for a significant short squeeze, citing high borrow rates and limited share availability. Some investors believe the stock could reach new highs, while others caution about the risks associated with low-float stocks and potential dilution.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending after reporting positive early-stage clinical data for its obesity drug, showing fat loss without muscle loss. The community is discussing the implications of these results, with some speculating about a potential buyout and others pointing out similarities to GLP-1 drugs. Overall sentiment is optimistic, though some caution against over-enthusiasm due to the early stage of the data.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending downwards amid concerns about the company's ability to deliver future products and a recent downgrade from Morgan Stanley. The community is expressing frustration and disappointment, with some questioning the company's long-term viability and management. Discussions include potential new strategies, comparisons to competitors like Tesla, and speculation about the influence of major investors.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending as traders discuss its potential for a low-float squeeze, drawing comparisons to recent runners in the same sector like $SMX. The community is analyzing the stock's float and short borrow fee, with some expressing caution due to a recent offering and warrant dilution. Overall, the focus remains on whether it can achieve a similar explosive move based on its low float.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending due to its impending inclusion in the S&P 500, driving significant after-hours gains and sparking debate about its valuation. While some celebrate this milestone after the stock's multi-year rebound, others express concerns about the company's fundamentals and accounting practices. Community discussions revolve around potential shorting opportunities and the implications of adding a high P/E stock to a major index.

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

Fulcrum Therapeutics Inc

Fulcrum Therapeutics is trending due to positive initial Phase 1b trial results for its sickle cell disease drug, Pociredir, sparking target price hikes. Community discussions focus on the drug's potential efficacy and clean safety profile, especially regarding increased fetal hemoglobin levels. The broader context includes the promising outlook for oral treatments in sickle cell disease and Fulcrum's potential as a leader in the field.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending due to positive topline data from its ACCESS program for Aleniglipron, an oral GLP-1 receptor agonist, sparking enthusiasm among longs. However, some investors are concerned about the lack of released safety data and comparing it to VKTX. The community is actively discussing the efficacy and potential market competition, with some speculating about a possible acquisition.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as investors debate the impact of competitor GPCR's data, particularly focusing on the lack of safety data released and potential implications for Viking's market position. Community discussions revolve around potential partnerships or a buyout, with some emphasizing Viking's strong pipeline and advanced stage in development. There is also ongoing speculation about the possibility of VK2809 skipping Phase 3 trials based on new FDA guidance.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending as traders discuss its low float and potential for a significant surge, drawing comparisons to other recent low-float runners. Community members are noting the company's recent profit outlook and speculating on possible price movements. Some traders caution against Hong Kong-based stocks while others express optimism for a breakout.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals (BDRX) is experiencing a surge in attention, driven by discussions around its low float and potential for a significant upside. Community members are actively discussing the stock's fundamentals, recent funding, and the upcoming Phase 3 trial news. The stock is also gaining traction as part of a broader low-float theme play.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CTGL 10 days since this exhaustive DD post and no other likes but one from me.   @SOD2Enthusiast a couple questions: 
 
Are you in  two way communication with Ora and/or the company? 
When do you think the company will start producing news and/or promotional materials? @Elevate1 Any idea of how much time I might have before it moves up a fair bit more, as I may well consider going in with up to 7500 more shares. (3x)

Bichon Begone

$CTGL CONFIDENTIAL MEMORANDUM
TO: Ora Elharar Soffer, Chief Executive Officer,
SkyTech Orion Global / Citrine Global Corp. (CTGL)
FROM: Strategic Analysis &amp; Business Development
DATE: November 27, 2025
RE: Strategic Opportunity Assessment: Modular Drone
Architecture &amp; U.S. Commercial Scaling 2026+
---
EXECUTIVE SUMMARY
Your &quot;Replicator&quot; modular drone platform, backed by
Israeli government support, Stratasys manufacturing
partnership, and multi-patent protection, represents a
rare opportunity to establish global market dominance
in commercial delivery logistics starting Q1 2026.
This memorandum outlines:
1. Why your modular architecture is economically
revolutionary for the $50B+ commercial delivery market
2. How Israeli government backing + Stratasys
partnership creates an unmatched competitive moat
3. Strategic recommendations for U.S. market scaling
and valuation acceleration
4. Projected outcomes: $5-10B acquisition price by
2027-2028 or $50-150/share public valuation by 2030
---
SECTION 1: THE STRATEGIC ASSET YOU HAVE BUILT
The Replicator is not just a drone. It is a &quot;capital
efficiency platform&quot; that fundamentally reshapes the
economics of commercial delivery logistics.
# Traditional Drone Fleet Model (Current Market
Standard)
* Problem: One drone = one mission profile
* Capital Inefficiency: Amazon must buy separate
drones for:
- Heavy-lift (5kg payloads, slow)
- Speed (0.5kg payloads, fast)
- Range extension (empty fuselage, long distance)
- Surveillance (no payload, sensors only)
* Result: ~40-50% fleet utilization; massive
redundant capital tied up in specialized airframes
# Replicator Modular Model (Your Innovation)
* Solution: One core airframe + modular
payload/motor/sensor configurations
* &quot;Click &amp; Fly&quot;: Swap components in minutes,
transform mission profile instantly
* Capital Efficiency: 80-90% utilization;
dramatically lower per-delivery cost
* Cost Advantage: $15-20/delivery vs. $25-
35/delivery with traditional fleets
---
SECTION 2: WHY YOUR TIMING IS HISTORIC
# A. U.S. Commercial Drone Delivery is Moving from
&quot;Concept&quot; to &quot;Scale&quot; (2026)
Current Status (Nov 2025):
* Amazon Prime Air: Limited operations (Texas,
Arizona)
* Wing (Alphabet): Slow scaling (residential
deliveries only)
* FAA Part 135 Waiver Status: Still restrictive;
mainly beyond-visual-line-of-sight (BVLOS) in limited
zones
2026 Inflection Point:
* FAA expected to grant broader BVLOS waivers
(Spring 2026)
* Amazon targeting 500+ delivery zones by end of
2026
programs
* Walmart, Target, FedEx all launching pilot
* Market is moving from &quot;R&amp;D&quot; to &quot;Scaling Phase&quot;
Your Timing: Q1 2026 production launch aligns
perfectly with market inflection.
# B. Israeli Government Backing De-Risks Your
Execution
The Israeli Ministry of Economy&#39;s multi-million-dollar
grant + designation of Yeruham as national drone
headquarters signals:
* Governmental Validation: Not a startup
speculation; a strategic national asset
* Supply Chain Security: Israeli government will
ensure operational continuity (no sanctions, no export
restrictions)
* Multi-Year Runway: Government backing = capital
certainty through 2027-2028
# C. Stratasys Partnership Creates Unfair Advantage
Why This Matters:
* Traditional drone makers = single factory =
bottleneck
* Your model = 3D-printed production anywhere
(Israel, U.S., Poland, Singapore)
* Stratasys materials = NDAA-compliant + defense-
grade durability
* Implication: You can scale to 50,000+ units
annually without factory constraints
---
SECTION 3: MARKET OPPORTUNITY &amp; REVENUE PROJECTIONS
# Total Addressable Market (TAM): $50B+ by 2030
| Segment | 2025 Revenue | 2030 Projected | CAGR |
| :--- | :--- | :--- | :--- |
| Commercial Parcel Delivery | $2B | $15B | 60% |
| Last-Mile Logistics | $5B | $25B | 38% |
| Government/Defense | $3B | $10B | 27% |
|
Total Addressable Market | $10B | $50B+ |
38-40% |
#
Your Market Share Scenarios (2030)
|
Scenario | Market Share | Revenue | Gross
Margin |
EBIT |
| :--- | :--- | :--- | :--- | :--- |
| Bull (IP Dominance) | 15-20% | $7.5-10B | 70% |
$2.5-3.5B |
| Base (Moderate Success) | 8-10% | $4-5B | 65% |
$1.3-1.6B |
| Bear (Commoditized) | 3-5% | $1.5-2.5B | 50% | $300-
400M |
Probability-Weighted 2030 Revenue: $3-6B
---
SECTION 4: COMPETITIVE MOAT &amp; PATENT PROTECTION
# Your Defensible Advantages
1. Multi-Patent Portfolio (U.S. + Israel)
- Click &amp; Flyâ„¢ mechanism (utility + design
patents)
- Multi-domain robotics framework (composition
claims)
- Estimated patent wall: 5-7 years of protection
before circumvention risk
2. Israeli Government Strategic Partnership
- IDF evaluation underway; potential procurement
contract
- Government exclusivity for defense applications
(de facto)
- Implication: Defense revenue stream ($500M-$1B
annually) is insulated from commercial competition
3. Stratasys Manufacturing Exclusivity
- No other drone maker has comparable 3D-printing
supply chain
- Supply chain security: Cannot be replicated by
Amazon/DJI without $200M+ Stratasys investment
4. First-Mover in Modular Standardization
- If you establish &quot;Click &amp; Fly&quot; as industry
standard (licensing to others), you own the &quot;iOS of
Drones&quot;
- Licensing model: 10-15% royalty on every modular
drone sold globally (even if competitors make the
airframe)
---
SECTION 5: PATH TO VALUATION ACCELERATION
# 2026 (Production Year)
Key Milestones:
- Q1 2026: First Replicator units produced at Yeruham
facility
- Q2 2026: FAA approvals for commercial deployment
- Q3 2026: First Amazon/Walmart/FedEx orders (pilot
volumes, 100-500 units)
- Q4 2026: Scale to 1,000-2,000 units; announce
Israeli government contract
Stock Price Impact:
- Current: ~$0.50-1.50/share (penny stock)
- Q1 2026 (Production achieved): $3-5/share (+200-
400%)
- Q2 2026 (FAA approval): $5-10/share (+400-900%)
- Q4 2026 (Major orders announced): $10-20/share
(+900-2,000%)
# 2027-2028 (Scaling Year)
Key Milestones:
- Scale to 10,000+ annual production
- Revenue run-rate: $500M-$1B
- Israeli government defense contract worth $200-500M
annually
- NASDAQ uplisting (requirements: $10M+ quarterly
revenue, $50M+ market cap)
Valuation Impact:
- Public comparable valuation: 3-5x revenue = $1.5-5B
market cap
- Stock price: $50-150/share (from current $0.50-1.50)
# 2029-2030 (Acquisition Year)
Acquisition Candidates:
- Amazon (strategic: accelerates logistics dominance)
- Northrop Grumman / RTX (strategic: defense robotics
platform)
- General Dynamics (strategic: modular autonomous
systems)
- Acquisition price: $5-10B (6-10x revenue at 2030
scale)
Stock Price at Acquisition:
- $50-150/share to $300-500/share (depending on
acquisition multiples)
---
SECTION 6: CRITICAL SUCCESS FACTORS (CSFs)
# 1. Q1 2026 Production Execution
Risk Level: HIGH
Mitigation:
- Establish production scorecard with measurable KPIs
(units/week)
- Secure secondary Stratasys facility in U.S. (backup
capacity)
- Pre-order customer commitments (FAA waivers
dependent) locked in writing
# 2. FAA Regulatory Approval (2026)
Risk Level: MODERATE
Mitigation:
- Engage FAA now (pre-Q1); submit regulatory strategy
by Q1 2026
- Partner with established aerospace consultants (Booz
Allen, Deloitte Consulting)
- Benchmark against Wing (Alphabet) and Prime Air
(Amazon) approval pathways
# 3. Israeli Defense Contract Lock-In (2026)
Risk Level: LOW
Mitigation:
- IDF evaluation is already underway; prioritize this
contract closure
- Government contract = revenue certainty + strategic
anchor
- Defense contract also serves as &quot;credibility moat&quot;
(de facto endorsement for commercial buyers)
# 4. Defend IP Against Amazon/Competitors
Risk Level: MODERATE-HIGH
Mitigation:
- Accelerate patent prosecution (add continuation
applications for design variants)
- Consider licensing strategy: offer Click &amp; Fly
royalty structure to potential competitors
- Build switching costs: customer software
integrations + training = high customer lifetime value
---
SECTION 7: STRATEGIC RECOMMENDATIONS FOR CEO
# 1. Immediately Secure Israeli Defense Ministry
Contract
Action:
Schedule meeting with Israeli Ministry of Defense
procurement team in December 2025. Lock in quantity
commitments for 2026-2027 ($300M+ contract).
Why:
This contract converts your technology from &quot;startup
speculation&quot; to &quot;de facto government-validated
system.&quot; Commercial customers (Amazon, Walmart) will
follow IDF&#39;s lead.
# 2. Announce Major U.S. Commercial Partnership (Q1
2026)
division
Target Partner: Amazon Prime Air or Walmart logistics
Deal Structure:
- Exclusive Replicator supply for 2,000-5,000 units
(2026-2027)
- Upfront payment: $50-100M
- Price per unit: $150-250K (vs. $200-400K for
competitors)
- Outcome: Pre-revenue secured; cash flow certainty
for scaling
# 3. Prepare for NASDAQ Uplisting (2027)
Timing: Once revenue reaches $10M+ quarterly (~Q2-Q3
2027)
IPO Strategy:
- Target price: $15-25/share at IPO
- Raise: $300-500M (capital for R&amp;D, marketing,
geopolitical hedging)
- Positioning: &quot;The Modular AI-Powered Drone Platform
Company&quot; (emphasize software/IP, not just hardware)
# 4. Establish Licensing Revenue Stream (2027+)
Model:
- Offer &quot;Click &amp; Fly&quot; standard license to qualified
manufacturers (RTX, AeroVironment, DJI)
- Royalty: 10-15% of drone sales using your modular
architecture
- Upside: $200-400M annually in royalties by 2030
(capital-light revenue)
---
SECTION 8: FINANCIAL PROJECTIONS &amp; VALUATION
# Conservative Case (2030)
|
|
|
|
|
Metric | 2026 | 2027 | 2028 | 2029
| 2030
|
:--- | :--- | :--- | :--- | :--- |
:--- |
Unit Sales | 500 | 2,000 | 5,000 |
12,000
| 18,000 |
| Revenue ($M) | $75 | $300 | $750 | $1,500 | $2,000 |
| Gross Margin % | 60% | 65% | 68% | 70% | 72% |
Licensing Revenue ($M) | $0 | $0 | $50 | $150 | $300
| Total Revenue ($M) | $75 | $300 | $800 | $1,650 |
$2,300 |
| EBIT Margin % | 10% | 20% | 30% | 35% | 40% |
| EBIT ($M) | $7.5 | $60 | $240 | $578 | $920 |
2030 Valuation (at 5x EBIT multiple): $4.6B â†’ $15-
30/share (depending on share count)
# Bull Case (2030)
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
| :--- | :--- | :--- | :-

StockTwits for iOS

Skytech Orion Global

Macy's Inc

SOD2 Enthusiast

StockTwits Web

 10 days since this exhaustive DD post and no other likes but one from me.   

 a couple questions: 
 
Are you in  two way communication with Ora and/or the company? 
When do you think the company will start producing news and/or promotional materials? 

 Any idea of how much time I might have before it moves up a fair bit more, as I may well consider going in with up to 7500 more shares. (3x)

Jim Bob

@dabbler22 @SOD2Enthusiast yes I talk to her. She gives me general research info not inside info! She has been so busy that the public info had to take a second level. I expect she will update us next week. What I feel is that we will be part of the next major army RFI and we will be among the winners. They are looking for 300 k suicide drones at $5 k each. We will be among the 10 winners. This is $150 mill and huge earnings if they win. This is all out there. You just need to look. Could she miss it, I doubt it! Stock will reflect it! I am long and will trade at will!

Cheese

 yes I talk to her. She gives me general research info not inside info! She has been so busy that the public info had to take a second level. I expect she will update us next week. What I feel is that we will be part of the next major army RFI and we will be among the winners. They are looking for 300 k suicide drones at $5 k each. We will be among the 10 winners. This is $150 mill and huge earnings if they win. This is all out there. You just need to look. Could she miss it, I doubt it! Stock will reflect it! I am long and will trade at will!